1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Creatine Kinase

Creatine Kinase

CK

Creatine Kinase (CK) is an enzyme that catalyzes the reversible reaction between creatine and ATP and belongs to the guanidine phosphokinase family. This family is highly conserved in the animal kingdom, and its members also include arginine kinase, guanidine acetate kinase, etc. There are four main isoenzymes of CK, which are divided into two cytoplasmic types (MM-CK and BB-CK, which can form MB heterodimers) and two mitochondrial types (the ubiquitous Mi₋CK and the sarcomeric Mi-CK). CK has multiple upstream and downstream or interaction targets in the cell. In the energy metabolism pathway, CK in mitochondria interacts closely with adenine nucleotide translocase (ANT) and participates in the regulation of mitochondrial respiration; some cytoplasmic CKs bind to glycolytic enzyme complexes, such as pyruvate kinase, phosphofructokinase, etc., affecting the glycolysis process. In terms of muscle contraction, CK interacts with myosin ATPase, Ca2+-ATPase of sarcoplasmic reticulum, Na+-K+-ATPase of sarcolemma, etc., to provide energy support for muscle contraction and relaxation. In addition, CK also interacts with proteins related to cell cycle regulation. For example, in cell cycle regulation, CK works synergistically with AK, NDPK, etc. The main function of CK is to maintain the energy homeostasis of cells. In cells with high and fluctuating energy demands, such as muscle and brain cells, CK converts ATP into PCr to store energy at ATP generation sites through the creatine phosphate-creatine (PCr-Cr) shuttle mechanism, and converts PCr into ATP at ATP consumption sites, thereby effectively buffering the fluctuation of ATP levels in cells and ensuring the stability of cellular energy supply. At the same time, CK is also involved in the regulation of cell metabolism, affecting the progress of related metabolic reactions by regulating the ATP/ADP ratio, and plays a key role in intracellular energy transport, connecting ATP generation processes such as glycolysis and mitochondrial oxidative phosphorylation with many intracellular ATP consumption processes. CK is closely related to many diseases. In myocardial and skeletal muscle diseases, it is an important diagnostic indicator. For example, in acute myocardial infarction, the CK level in serum will increase significantly, especially the CK-MB isoenzyme, which can assist in judging myocardial damage. In muscle diseases such as Duchenne muscular dystrophy, the patient's serum CK activity is significantly increased. In terms of nervous system diseases, the lack of brain-type CK can lead to behavioral changes, spatial learning and memory dysfunction and other problems. In addition, CK also plays an important role in the occurrence and development of cancer. It participates in the energy metabolism, cell cycle regulation and cell migration of cancer cells. Abnormal CK levels are associated with a variety of cancers, such as ovarian cancer and breast cancer, and are expected to become a biomarker and therapeutic target for cancer diagnosis[1][2][3][4][5][6][7][8].

Creatine Kinase Related Products (8):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P2799A
    Creatine Kinase (CPK/CK), Bovine Heart
    Creatine Kinase (CPK/CK), Bovine Heart (CK) is a creatine kinase derived from bovine heart. Creatine Kinase (CPK/CK), Bovine Heart catalyzes the reversible phosphate transfer reaction between phosphocreatine and ADP, and is widely used in myocardial energy metabolism research and quality control of clinical biochemical tests.
    Creatine Kinase (CPK/CK), Bovine Heart
  • HY-D1005A25
    Poloxamer 403 (P123)
    Activator
    Poloxamer 403 P123 is a block copolymer of polyoxyethylene and polyoxypropylene with an average molecular weight of 5750. Poloxamer has the ability to inhibit P-gp. Poloxamer 403 increases creatine kinase levels. Poloxamer 403 is myotoxic.
    Poloxamer 403 (P123)
  • HY-181584
    AKI-062a
    Inhibitor
    AKI-062a is a non-selective kinase inhibitor, such as a CK1γ inhibitor. AKI-062a binds to and inhibits WNT pathway kinases and GSK3β. At a concentration of 1 μM, AKI-062a binds to 17 kinases, with a binding activity of <10% of that of the control group.
    AKI-062a
  • HY-183265
    GO847
    Inhibitor
    GO847 is an orally active casein kinase 2 (CK2) inhibitor with an IC50 of 40.2 nM. GO847 increases intracellular ATP levels, impairs Mitochondrial metabolic flexibility, and promotes excessive mitochondrial ROS production. GO847 alters the period length of cellular circadian rhythms. GO847 inhibits the growth of acute myeloid leukemia cells. GO847 can be used for the research of acute myeloid leukemia.
    GO847
  • HY-P2799I
    Creatine Kinase BB (CK-BB), human brain
    Creatine Kinase BB (CK-BB), human brain is a specific isoenzyme of creatine kinase (E.C. 2.7.3.2) primarily derived from human brain tissue. Creatine Kinase BB can be used for the study of radioimmunoassay techniques.
    Creatine Kinase BB (CK-BB), human brain
  • HY-148150A
    Cyclocreatine phosphate dilithium
    Inhibitor
    Cyclocreatine phosphate dilithium is a synthetic intracellular energy buffer. Cyclocreatine phosphate dilithium mediates antiproliferative activity in cells with high creatine kinase levels and inhibits solid tumor growth. Cyclocreatine phosphate dilithium maintains adenosine triphosphate (ATP) levels and protects tissues from hypoxia, cellular damage and inflammation during ischemic events. Cyclocreatine phosphate dilithium accumulates in skeletal muscle, reduces muscle phosphocreatine and total creatine levels, and acts both as a bioenergetic/anti-inflammatory agent and an experimental tool for the assessment of ischemic injury. Cyclocreatine phosphate dilithium can be used in studies related to solid tumors, heart failure and ischemia.
    Cyclocreatine phosphate dilithium
  • HY-181753
    INSP-0154
    INSP-0154 is a potent creatine kinase B (CKB)/creatine transporter (SLC6A8) inhibitor. INSP-0154 binds to the SLC6A8 occluded pocket, prevents creatine transport into cells, and protects SLC6A8 cysteine residue C144 from irreversible inactivation. INSP-0154 inhibits creatine uptake in mouse heart tissue. INSP-0154 can be used for the research of cancer.
    INSP-0154
  • HY-E70969
    Creatine Kinase, Porcine
    Creatine Kinase, Porcine (EC 2.7.3.2) is an enzyme present in muscle, brain, and other tissues of vertebrates that catalyzes the reversible conversion of ADP and phosphocreatine into ATP and creatine.
    Creatine Kinase, Porcine